LaVoieHealthScience to Begin Working with Life Sciences Corridor

LaVoieHealthScience (LHS), an integrated investor and public relations agency focused on advancing health and science innovations, today announced engagement with the Life Sciences Corridor, a partnership among five Greater Boston cities including Boston, Braintree, Cambridge, Quincy and Somerville. LHS will leverage content and optimize social media channels on behalf of Life Sciences Corridor to ensure visibility for the Corridor’s unique offering of talent, facilities and connections for life science companies.

The Life Sciences Corridor is an initiative launched by the mayors of the five Greater Boston communities to promote the robust life sciences sector along the MBTA red line. Nicknamed “the brain train,” the cluster represents more than 460 companies within the life science industry sector. With the goal of attracting business from outside the region as well as retaining businesses within the region, the Corridor also promotes cross collaboration among universities, institutions and businesses.

“As contributors to the health and life science ecosystem in the Greater Boston Area, LHS welcomes the opportunity to work with an initiative whose mission includes helping companies understand the advantages and offerings of companies in the Corridor,” said Donna L. LaVoie, President and CEO of LaVoieHealthScience. “We have been aligned with leaders in the life science sector since its infancy more than 15 years ago and we look forward to connecting with the various companies and helping grow this already flourishing industry.”

“For years, Cambridge has been planning for new major economic development opportunities, including the Volpe Center and Cambridge Crossing projects, and we are looking forward to continuing our collaboration with Boston, Quincy, Somerville, and Braintree to support the life sciences industry in Massachusetts,” said Cambridge City Manager Louis A. DePasquale. “The partnership between the five cities of the Life Sciences Corridor is helping transform the regional economy by bolstering support for hundreds of life sciences companies.”

“Boston is home to a growing network of businesses, entrepreneurs, researchers, employees, and job seekers actively contributing to life saving technologies and innovation within the region's life sciences cluster,” said John Barros, Chief of Economic Development in the City of Boston. “By collaborating with our neighboring cities, all connected by the Red Line of our transit system, we are leveraging shared resources to further position the Boston region as a global leader for the life sciences industry."

“For anyone outside of Massachusetts seeking to grow their business, the Boston region has always been defined broadly, and this partnership will embrace that,” said Braintree Mayor Sullivan.

“It’s an opportunity that benefits everyone involved,” said Quincy Mayor Koch. “This partnership will capture the immediate impacts on business development and institutional growth.”

“It’s great to see these five cities working with a local agency that specializes in the life science field,” said Somerville Mayor Curtatone. “They understand not only the local ecosystem, but also how to target outside, national audiences to drive growth.”

About LaVoieHealthScience
LaVoieHealthScience partners with leading health and science brands to build value for their companies, attract capital and reach key stakeholders through integrated communications and marketing. The firm provides strategic communications, investor relations and public relations to build recognition and increase sales and value for health science innovations. The agency has received 29 awards over the past seven years in recognition of the work it has done for its health and science industry-leading clients, and is ranked among the 2017 Inc. 5000 list of fastest growing private companies for the fourth year. LaVoieHealthScience represents other life science leaders such as Ampio Pharmaceuticals, Biotechnology Innovation Organization, Fusion Pharmaceuticals, Iota BioSciences, Landos Biopharma, LEO Science Hub, NewLink Genetics, Newron Pharmaceuticals, Oncocyte, Origenis, Savara, Xontogeny LLC and other emerging health and science companies. Follow LHS on Twitter at @LaVoieGroup.

View source version on businesswire.com: http://www.businesswire.com/news/home/20180116006219/en/